Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 39.60
-0.10 (-0.25%)
May 20, 2026, 5:24 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 463.75 million as of May 21, 2026. Its market cap has increased by 140.65% in one year.
Market Cap
463.75M
Enterprise Value
472.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
39.60
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 463.75M, an increase of 3,651.23%. That is a compound annual growth rate of 29.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 463.75M | 58.20% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 323.76M |
| Matricelf | 82.12M |
| Clal Biotechnology Industries | 47.05M |
| BioLineRx | 33.94M |
| BioLight Life Sciences | 28.72M |
| Evogene | 21.74M |
| Can-Fite BioPharma | 20.76M |
| Purple Biotech | 18.59M |